beta

ARDM

Aradigm Corporation

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Aradigm Corp is a specialty pharmaceutical company. The Company is engaged in the development and commercialization of drugs delivered by inhalation for the prevention and treatment of severe respiratory diseases.

Market Cap: 33.9 Million

Primary Exchange: NASDAQ Capital Market

Website: http://www.aradigm.com

Shares Outstanding: 15.1 Million

Float: 11.8 Million

Dividend: 0.0 (0.0%)

Beta: 0.686654

Sector: Healthcare

Industry: Drug Manufacturers

Ethical Flags

Longest drawdown: 1090 trading days

From: 2014-09-12 To: 2019-01-16

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud